We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.85B
AUM Growth
+$49.7M
Cap. Flow
-$75.1M
Cap. Flow %
-2.64%
Top 10 Hldgs %
41.46%
Holding
236
New
11
Increased
27
Reduced
106
Closed
12

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$11.8M
2
CACC icon
Credit Acceptance
CACC
+$5.56M
3
RDNT icon
RadNet
RDNT
+$4.84M
4
EPD icon
Enterprise Products Partners
EPD
+$3.54M
5
WAB icon
Wabtec
WAB
+$2.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$28.9M
2
QCOM icon
Qualcomm
QCOM
+$10M
3
DOV icon
Dover
DOV
+$6.22M
4
ABT icon
Abbott
ABT
+$3.3M
5
BX icon
Blackstone
BX
+$2.94M

Sector Composition

Rank Sector Weight
1 Financials 30.9%
2 Healthcare 16.7%
3 Technology 13.21%
4 Industrials 9.38%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$158M 5.54%
1,176,883
-18,807
-2% -$2.39M
BX icon
2
Blackstone
BX
$104B
$146M 5.12%
3,281,673
-73,833
-2% -$2.94M
CACC icon
3
Credit Acceptance
CACC
$5.82B
$143M 5.03%
295,742
+11,692
+4% +$5.56M
ROP icon
4
Roper Technologies
ROP
$40.4B
$129M 4.54%
352,599
-4,541
-1% -$1.61M
ESGR
5
DELISTED
Enstar Group
ESGR
$128M 4.49%
733,417
+11,289
+2% +$1.96M
APO icon
6
Apollo Global Management
APO
$69B
$121M 4.25%
3,530,125
-48,477
-1% -$1.54M
LUMN icon
7
Lumen
LUMN
$6.43B
$93.1M 3.27%
7,917,835
+1,052,428
+15% +$11.8M
ABT icon
8
Abbott
ABT
$188B
$91.4M 3.21%
1,086,535
-41,918
-4% -$3.3M
LH icon
9
Labcorp
LH
$25.2B
$88.8M 3.12%
597,997
+1,319
+0.2% +$184K
WAT icon
10
Waters Corp
WAT
$37.3B
$82M 2.88%
380,916
-6,560
-2% -$1.43M
MTDR icon
11
Matador Resources
MTDR
$6.04B
$81.3M 2.86%
4,088,663
-67,613
-2% -$1.28M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.11T
$77.9M 2.74%
1,442,120
-12,680
-0.9% -$732K
JPM icon
13
JPMorgan Chase
JPM
$916B
$70.1M 2.46%
626,710
-3,420
-0.5% -$377K
AWI icon
14
Armstrong World Industries
AWI
$7.37B
$66M 2.32%
678,547
-23,900
-3% -$2.14M
WAB icon
15
Wabtec
WAB
$49.3B
$63.2M 2.22%
880,748
+38,048
+5% +$2.7M
MKL icon
16
Markel Group
MKL
$25.2B
$62.3M 2.19%
57,148
-1,778
-3% -$1.86M
EPD icon
17
Enterprise Products Partners
EPD
$83.7B
$61.4M 2.16%
2,128,334
+122,883
+6% +$3.54M
BUD icon
18
AB InBev
BUD
$164B
$60.6M 2.13%
684,653
-18,149
-3% -$1.56M
JNJ icon
19
Johnson & Johnson
JNJ
$640B
$50.9M 1.79%
365,437
-4,412
-1% -$611K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.1T
$49.9M 1.75%
234,204
-4,394
-2% -$909K
SHW icon
21
Sherwin-Williams
SHW
$84.8B
$48M 1.69%
314,115
-1,761
-0.6% -$263K
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.12T
$44.6M 1.57%
823,960
-19,060
-2% -$1.1M
QCOM icon
23
Qualcomm
QCOM
$164B
$42.8M 1.5%
562,756
-137,109
-20% -$10M
AXP icon
24
American Express
AXP
$224B
$42.7M 1.5%
345,986
-9,210
-3% -$1.08M
BAX icon
25
Baxter International
BAX
$12.8B
$41M 1.44%
500,799
-21,711
-4% -$1.69M
1
2 3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2019 Portfolio in Review

As of Q2 2019, Beck Mack & Oliver held 236 positions worth $2.85B, up 1.8% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Beck Mack & Oliver's Q2 2019 filing shows 11 new, 27 increased, 106 reduced and 12 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K. The largest sale was Teva Pharmaceuticals, an estimated $28.9M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2019 buy was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K.
  • Beck Mack & Oliver added most to Lumen in Q2 2019, an estimated $11.8M increase.
  • Beck Mack & Oliver's biggest Q2 2019 reduction was Teva Pharmaceuticals, cutting an estimated $28.9M.
  • Beck Mack & Oliver fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $656K.
  • Beck Mack & Oliver's ten largest holdings make up 41% of its $2.85B portfolio in Q2 2019.
  • Beck Mack & Oliver opened 11 new positions and closed 12 in Q2 2019.
  • Beck Mack & Oliver's portfolio value rose 1.8% quarter-over-quarter to $2.85B.

Based on Beck Mack & Oliver's 13F filing for Q2 2019, filed 13 Aug 2019.